These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16399018)

  • 1. Treatment with GH and IGF-1 in critical illness.
    Teng Chung T; Hinds CJ
    Crit Care Clin; 2006 Jan; 22(1):29-40, vi. PubMed ID: 16399018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with growth hormone and insulin-like growth factor-I in critical illness.
    Carroll PV
    Best Pract Res Clin Endocrinol Metab; 2001 Dec; 15(4):435-51. PubMed ID: 11800516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a role for growth hormone therapy in refractory critical illness?
    Taylor BE; Buchman TG
    Curr Opin Crit Care; 2008 Aug; 14(4):438-44. PubMed ID: 18614909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone: secretion and administration in catabolic adult patients, with emphasis on the critically ill patient.
    Voerman HJ; Strack van Schijndel RJ; de Boer H; van der Veen EA; Thijs LG
    Neth J Med; 1992 Dec; 41(5-6):229-44. PubMed ID: 1494402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein metabolism and the use of growth hormone and insulin-like growth factor-I in the critically ill patient.
    Carroll PV
    Growth Horm IGF Res; 1999 Dec; 9(6):400-13. PubMed ID: 10629160
    [No Abstract]   [Full Text] [Related]  

  • 6. Endocrinology in intensive care medicine: new insights and therapeutic consequences.
    Van den Berghe G
    Verh K Acad Geneeskd Belg; 2002; 64(3):167-87; discussion 187-8. PubMed ID: 12238241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone in HIV/AIDS: current uses and future prospects.
    Laurence J
    Pediatr AIDS HIV Infect; 1995 Oct; 6(5):281-91. PubMed ID: 11361393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive human growth hormone therapy in nutrition support: potential to limit septic complications in intensive care unit patients.
    Ziegler TR; Leader I
    Semin Respir Infect; 1994 Dec; 9(4):240-7. PubMed ID: 7886321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes within the GH/IGF-I/IGFBP axis in critical illness.
    Mesotten D; Van den Berghe G
    Crit Care Clin; 2006 Jan; 22(1):17-28, v. PubMed ID: 16399017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of growth factors with particular focus on growth hormone and insulin-like growth factor-1 in the management of chronic kidney disease.
    Feldt-Rasmussen B; El Nahas M
    Semin Nephrol; 2009 Jan; 29(1):50-8. PubMed ID: 19121474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whither growth hormone in the catabolic state of critical illness?
    Van Den Berghe G
    Growth Horm IGF Res; 1999 Dec; 9(6):397-9. PubMed ID: 10629159
    [No Abstract]   [Full Text] [Related]  

  • 12. Growth hormone administration during nutritional support: what is to be gained?
    Ziegler TR
    New Horiz; 1994 May; 2(2):244-56. PubMed ID: 7922450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone therapy in adults: rationales, results, and perspectives.
    Riedel M; Brabant G; Rieger K; von zur Mühlen A
    Exp Clin Endocrinol; 1994; 102(4):273-83. PubMed ID: 7813598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired growth hormone resistance in patients with hypercatabolism.
    Bentham J; Rodriguez-Arnao J; Ross RJ
    Horm Res; 1993; 40(1-3):87-91. PubMed ID: 7507879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of recombinant human growth hormone in HIV-associated wasting and cachexia: pathophysiology and rationale for treatment.
    Gelato M; McNurlan M; Freedland E
    Clin Ther; 2007 Nov; 29(11):2269-88. PubMed ID: 18158071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic aspects of growth hormone and insulin-like growth factor-I treatment on visceral fat and insulin sensitivity in adults.
    Yuen KC; Dunger DB
    Diabetes Obes Metab; 2007 Jan; 9(1):11-22. PubMed ID: 17199714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of treatment with recombinant human GH and IGF-I on visceral adipose tissue and glucose homeostasis in adults.
    Yuen KC; Dunger DB
    Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S55-61. PubMed ID: 16624605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes within the growth hormone/insulin-like growth factor I/IGF binding protein axis during critical illness.
    Mesotten D; Van den Berghe G
    Endocrinol Metab Clin North Am; 2006 Dec; 35(4):793-805, ix-x. PubMed ID: 17127147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and growth hormone (GH) therapy in children with GH deficiency: experience in King Chulalongkorn Memorial Hospital, Thailand.
    Wacharasindhu S; Supornsilchai V; Aroonparkmongkol S; Srivuthana S
    J Med Assoc Thai; 2007 Oct; 90(10):2047-52. PubMed ID: 18041422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibitory effects of interleukin-1 on growth hormone action during catabolic illness.
    Cooney RN; Shumate M
    Vitam Horm; 2006; 74():317-40. PubMed ID: 17027521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.